24 Outcome in metastatic NSCLC without EGFR and KRAS mutation treated with second line erlotinib

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2014, Vol.83, p.S10-S10
Main Authors: Dua, D, Montes, A, Warner, M, Spicer, J, Lal, R
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Pulmonary/Respiratory
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0169-5002
1872-8332
DOI:10.1016/S0169-5002(14)70025-X